ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
4.875
-0.475 (-8.88%)
At close: Nov 20, 2024, 4:00 PM
4.850
-0.025 (-0.51%)
Pre-market: Nov 21, 2024, 7:42 AM EST
ImmunityBio Market Cap
ImmunityBio has a market cap or net worth of $3.40 billion as of November 21, 2024. Its market cap has increased by 105.11% in one year.
Market Cap
3.40B
Enterprise Value
4.29B
1-Year Change
105.11%
Ranking
Category
Stock Price
$4.88
Market Cap Chart
Since July 28, 2015, ImmunityBio's market cap has increased from $2.67B to $3.40B, an increase of 27.42%. That is a compound annual growth rate of 2.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 3.40B | 1.35% |
| Dec 29, 2023 | 3.35B | 65.16% |
| Dec 30, 2022 | 2.03B | -16.05% |
| Dec 31, 2021 | 2.42B | 67.01% |
| Dec 31, 2020 | 1.45B | 288.28% |
| Dec 31, 2019 | 372.80M | 305.66% |
| Dec 31, 2018 | 91.90M | -74.24% |
| Dec 29, 2017 | 356.80M | -24.28% |
| Dec 30, 2016 | 471.20M | -66.52% |
| Dec 31, 2015 | 1.41B | -47.21% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rhythm Pharmaceuticals | 3.65B |
| Acadia Healthcare Company | 3.63B |
| Denali Therapeutics | 3.51B |
| Envista Holdings | 3.51B |
| Apellis Pharmaceuticals | 3.42B |
| BrightSpring Health Services | 3.27B |
| PTC Therapeutics | 3.24B |
| Neogen | 3.23B |